Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-01FDA Approved: LIOMNY — Supplemental Application (SIGMAPHARM LABORATORIES, LLC)
FDA approved a supplemental application for LIOMNY (liothyronine sodium) from SigmaPharm Laboratories LLC.
-
FDA approval · 2025-06-12FDA Approved: LIOMNY — Supplemental Application (SIGMAPHARM LABORATORIES, LLC)
FDA approved a supplemental application for LIOMNY (liothyronine sodium) submitted by SigmaPharm Laboratories, LLC.
-
FDA approval · 2025-05-01FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Levothyroxine sodium (generic) from Mylan Pharmaceuticals Inc., authorizing an additional ap…
-
FDA approval · 2025-03-05FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Fosun Pharma USA Inc.)
FDA approves Fosun Pharma USA Inc.'s Levothyroxine Sodium anhydrous as a generic product under Original ANDA for thyroid hormone replacement…
-
FDA approval · 2024-09-24FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Levothyroxine Sodium (generic levothyroxine) under ANDA 209713.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's levothyroxine sodium, resulting in a generic product approval for thyroid ho…
-
FDA approval · 2024-09-10FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for LEVOTHYROXINE SODIUM (Teva Pharmaceuticals, Inc.). The approval concerns changes to the product …
-
FDA approval · 2024-07-16FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic levothyroxine sodium product from Aurobindo Pharma Limited via an Original Application (ANDA), authorizing its use as…
-
FDA approval · 2024-02-20FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, resulting in changes to the product's labeling.
-
FDA approval · 2024-02-06FDA Approved: LIOTHYRONINE SODIUM — Original Application (Biocon Pharma Inc.)
FDA approved Liothyronine sodium (Biocon Pharma Inc.) under an Original Application (ANDA) as a generic treatment for hypothyroidism.
-
FDA approval · 2023-11-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium by Alvogen, Inc., updating the regulatory status for this product under…
-
FDA approval · 2023-08-08FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for levothyroxine sodium from Teva Pharmaceuticals under ANDA 207588. This represents a routine …
-
FDA approval · 2023-07-21FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Levothyroxine Sodium, a generic product used to treat hypothyroidism and re…
-
FDA approval · 2023-03-24FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original ANDA for Levothyroxine Sodium from Zydus Pharmaceuticals USA Inc., expanding access to a generic thyroid hormone r…
-
FDA approval · 2023-01-18FDA Approved: LEVOTHYROXINE SODIUM — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original application for levothyroxine sodium from XLCare Pharmaceuticals, Inc.
-
FDA approval · 2022-12-21FDA Approved: LEVOTHYROXINE SODIUM — Original Application (NorthStar RxLLC)
FDA approved the original application for levothyroxine sodium as a generic thyroid hormone replacement product from NorthStar RxLLC.
-
FDA approval · 2022-10-31FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for levothyroxine sodium from Accord Healthcare Inc. under an ANDA.
-
FDA approval · 2022-09-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's levothyroxine sodium, a generic thyroid hormone replacement product.
-
FDA approval · 2022-06-22FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) filed by IBSA Pharma Inc., typically resulting in labeling u…
-
FDA approval · 2022-05-10FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva’s generic levothyroxine sodium product under an Original Application (ANDA 207588).
-
FDA approval · 2022-04-29FDA Approved: ERMEZA — Original Application (Viatris Specialty LLC)
ERMEZA has been approved by the FDA through an original NDA for levothyroxine sodium, a thyroid hormone replacement used to treat hypothyroi…
-
FDA approval · 2022-04-27FDA Approved: EUTHYROX — Supplemental Application (Provell Pharmaceuticals, LLC)
The FDA approved a supplemental application for EUTHYROX (levothyroxine sodium) from Provell Pharmaceuticals, LLC, updating an existing NDA …
-
FDA approval · 2021-05-17FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a Levothyroxine Sodium original application product from Hikma Pharmaceuticals USA Inc. as a thyroid hormone replacement therap…
-
FDA approval · 2021-05-17FDA Approved: LIOTHYRONINE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for liothyronine sodium from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2021-01-22FDA Approved: LIOTHYRONINE SODIUM — Original Application (Zydus Lifesciences Limited)
FDA approved a generic liothyronine sodium product from Zydus Lifesciences Limited under an Original Application (ANDA). It is used for the …